The histamine H 3 receptor is a central inhibitory autoreceptor located on histaminergic nerve terminals that are found mainly on cholinergic and dopaminergic neurons. H3 receptor activation resulted in a reduction of the release of histamine in the brain, whereas its inhibition (by inverse agonist or antagonist) increased the release of histamine [1] [2] [3] propyloxy) phenyl ketone) is an extremely potent histamine H 3 receptor (H 3 R) inverse agonist/antagonist which enhanced the release of histamine and increases sustained attention and alertness states. [4] [5] [6] Both thioperamide (a potent HRH3 antagonist) and ciproxifan enhance working memory 4,7-10 and long-term memory 11-17 and counteract scopolamine-induced amnesia. 11, 12, [18] [19] [20] [21] The therapeutic use of procognitive compounds might be integrated into a stressful context. Indeed, patients suffering 
| INTRODUC TI ON
The histamine H 3 receptor is a central inhibitory autoreceptor located on histaminergic nerve terminals that are found mainly on cholinergic and dopaminergic neurons. H3 receptor activation resulted in a reduction of the release of histamine in the brain, whereas its inhibition (by inverse agonist or antagonist) increased the release of histamine [1] [2] [3] . Ciproxifan (cyclopropyl 4-(3-(1H-imidazol-4-yl)
propyloxy) phenyl ketone) is an extremely potent histamine H 3 receptor (H 3 R) inverse agonist/antagonist which enhanced the release of histamine and increases sustained attention and alertness states. [4] [5] [6] Both thioperamide (a potent HRH3 antagonist) and ciproxifan enhance working memory 4, [7] [8] [9] [10] and long-term memory [11] [12] [13] [14] [15] [16] [17] and counteract scopolamine-induced amnesia. 11, 12, [18] [19] [20] [21] The therapeutic use of procognitive compounds might be integrated into a stressful context. Indeed, patients suffering pairs hippocampus-dependent memory retrieval. 23 The deleterious effect of stress on cognitive functions is observed in stress-related disorders such as anxiety and depression. [24] [25] [26] In such context, histaminergic system is a relevant target because histamine is an indicator of stress response [27] [28] [29] [30] [31] [32] since stress is a potent activator of histamine neurons in the tuberomammillary nucleus of the hypothalamus. 33 A consensus view is that histamine antagonists have more impact in tasks having an anxiety component. 34 For example, it has been found that ciproxifan prevented the deleterious effects of chronic stress exposure in spatial memory. 35 In contrast, central administration of histamine can also increase plasma corticosterone via its action on hypothalamic neuropeptides 36 and promotes anxiety-like behavior. [37] [38] [39] [40] Research efforts are now needed to determine emotional impact of H 3 R antagonists at procognitive dose.
Although numerous studies concerned procognitive action of 3 mg/kg ciproxifan in control (nonstressed) conditions, 4, [8] [9] [10] [11] its cognitive action in hippocampus-dependent memory in stress condition has not been yet studied and more particularly at the retrieval phase. 41 To that aim, we investigated the effects of an acute stress (three electric footshocks 0.9 mA) on memory in a contextual serial spatial discrimination task (CSD) where stress is not directly associated with the memory task. In the CSD task, mice learned two successive discriminations and are tested 24 hours later for memory of the first or second discrimination using distinct internal context in mice. 42 We previously showed that memory of the first discrimination involved the dorsal hippocampus in nonstress condition, whereas memory of the second discrimination involved the prefrontal cortex and the amygdala in stress condition. 43, 44 Using this behavioral model, we investigated in a first experiment the effects of pre-test injection of 3 mg/kg ciproxifan on memory of D1 and D2 in nonstress or stress conditions. Fos immunohistochemistry has been found to be a powerful tool for identifying the modifications of neural activity in brain areas particularly after stress. For example, the number of immunostained cells was increased in the amygdala of animals submitted to stressful situations. 45, 46 Therefore, in a first experiment, the impact of ciproxifan on Fos expression was performed in brain areas involved in the CSD behavioral task such as the prefrontal cortex (PrL for prelimbic and Il for infralimbic cortex), the dorsal hippocampus (CA1, CA3 for Cornu Ammonis areas 1 and 3 and DG for dentate gyrus) and lateral (LA), basolateral (BLA) and central (CeA) nucleus of amygdala. A second experiment was designed to study the effect of ciproxifan 3 mg/kg on emotional reactivity in the elevated plus maze (EPM) behavior and plasma corticosterone levels. 47 This second experiment was designed to determine if the 3 mg/kg procognitive dose of ciproxifan could be dissociated from its emotional impact.
| MATERIAL AND ME THODS

| Animals
144 subjects were 3-month-old male mice of the C57Bl/6J inbred strain obtained from Charles River and assigned to Experiment 1 (eight groups of 13; n = 104) and Experiment 2 (four groups; n = 40).
All mice were maintained in a ventilated colony room at 22 ± 1°C, under a 12:12 light-dark cycle (lights on at 7:00 am). They were pro- F I G U R E 1 Contextual Serial spatial Discriminations (CSD) protocol. Mice were ip injected (vehicle solution for all groups) 30 min before acquisition phase then were exposed to the first discrimination D1 (only one hole on 4 is randomly baited by ten 20-mg saccharose pellets) on a specific floor (white and smooth; random use for each mouse). Note that each treatment is done in a specific room. In the second discrimination (D2), the baited hole is in the opposite corner than discrimination 1 and the color and texture of the floor is changed (black and rough). On the following day, mice were randomly treated (ip injection and acute stress, 30 and 15 min before behavioral test respectively). During the retrieval test phase, no hole is baited and mice were randomly exposed to either D1 or D2 floor (independent groups) after treatment.
| Procedures
| Experiment 1: effects of ciproxifan on memory and neural activities
Contextual serial discrimination (CSD) task can be considered as reflecting a unique event-related memory.
48
Drug administration
All animals were injected intraperitoneally with vehicle 30 minutes before the acquisition phase (0.9% saline solution; 0.1 ml/10 g body weight; Figure 1 ). During the test session, the animals randomly received either the vehicle solution or ciproxifan (3 mg/kg/body weight diluted in a 0.9% saline solution) 30 minutes before behavioral assessment. The dose of ciproxifan was chosen according to previous studies.
4,8-11
Stress administration
Fifteen minutes before behavioral test (CSD and EPM tests), mice
were randomly chosen and placed in the stress delivery cage for 1 minute. Three consecutive inescapable electric footshocks (0.9 mA; 15 ms) were delivered every 20 seconds.
Immunohistochemical procedure
Ninety minutes after test, mice were killed under deep anesthesia 
| Experiment 2: effects of ciproxifan and stress on behavioral and endocrinal reactivity
General protocol Drug injections (vehicle or ciproxifan 3 mg/kg) and stress (three footshocks 0.9 mA) were performed respectively 30 minutes and 15 minutes before EPM. Mice were randomly assigned to four experimental groups (NS Veh; NS Cipro3, Str Veh; Str Cipro3).
Elevated plus maze
The EPM consisted of two open-arms (30 cm long, 7 cm wide) and 
Plasma corticosterone
At the end of the EPM task, animal were decapitated, trunk blood was immediately centrifuged at 4°C and plasma was stored at −20°C until corticosterone assay. Corticosterone concentrations were quantified using a commercially Enzyme Immunoassay kit (DetectX, Arbor Assays).
The limit of detection of this assay was 1.7 µg/dL that is 4-fold lower than the minimal value (8.05 µg/dL) obtained in the present study.
| Statistical analysis
The normality of the distribution was evaluated using Shapiro-Wilk test.
Data are displayed with bar graph representing mean ± SEM (standard error mean). One or two-way factorial analysis of variance (ANOVA) of drug and stress factors were performed for behavioral analyses (experiment 1 and 2) and plasma corticosterone assay followed by post hoc comparisons (Scheffe multiple comparison test; two-sided method adjustment). Insofar that stress increase Fos immunoreactivity, 50 the interaction between drug and stress factors was not performed. Therefore, drug effect on Fos staining in nonstressed animals was analyzed independently of stressed animals by the mean of unpaired t test. The significance level was set at P < 0.05, nonsignificant results are reported as NS. Statistical analysis was performed using Statistica ® 7.0. software.
| RE SULTS
3.1 | Experiment 1: Impact of ciproxifan on memory retrieval and neural activities in stress and nonstress conditions
| Contextual serial discrimination (CSD)
Acquisition. The number of animals per group is mentioned in Table 1 .
No significant between-groups difference was observed both for the total number and the percentage of head-dips in the baited hole, both for discrimination 1 and Discrimination 2) (P > 0.10 in all analyses).
Test phase (see Figure 2 ).
Correct responses
Percentages of correct responses were above chance level (25%) for
Vehicle-D1, Cipro-D1 and Cipro-D2 in nonstressed animals (t = 7.96, P < 0.0001; t = 2.04, P < 0.05; t = 4.5, P < 0.01, respectively) and for Vehicle-D2, Cipro-D1 and Cipro-D2 in stressed mice (t = 10.01, P < 0.0001; t = 2.95, P < 0.01 and t = 2.98, P < 0.01 respectively). A global ANOVA revealed a significant interaction between drug, discrimination and stress factors (F(3, 87) = 20.3; P = 0.0001; Figure 2A ).
Correct responses in nonstressed animals
Ciproxifan effect In nonstress condition, ANOVA revealed a significant interaction between drug and discrimination (F(2, 41) = 19.70; P < 0.0001). Ciproxifan 3.0 mg/kg decreased the % of correct responses at D1 (32.4% ± 6.6% for ciproxifan group versus 48.5% ± 2.3% for vehicles; Scheffe post hoc test, P < 0.05) but increased D2 correct responses rates (41.3% ± 3.6% vs 27.6% ± 3.0%; P < 0.05).
Discrimination effect Vehicle-treated mice exhibited a higher % of correct responses for D1 (48.5% ± 2.3%) as compared to D2 (27.6% ± 3.0%;
Scheffe post hoc test: P < 0.01) whereas correct responses % of ciproxifantreated animals were not different between both discrimination (32.4% ± 3.6% vs 41.3% ± 3.6% for D1 and D2 respectively; NS).
Correct responses in stressed animals
Ciproxifan effect In stress condition, ANOVA also revealed a significant interaction between drug and discrimination (F(2, 46) = 5.56; P < 0.05): ciproxifan increased the % of correct responses at D1 (3.6% ± 3.7% for ciproxifan group versus 25.3% ± 3.3%
TA B L E 1 Behavioral performances during acquisition phase in CSD task For the eight studied groups, effective ("N" column), discrimination (DISCRI), drug (VEH = vehicle; CIPRO3 = ciproxifan 3 mg/kg) and stress (stress = 3 acute electric footshocks 0.9 mA; NS = nonstress) are mentioned. Data are expressed by the mean + SEM of total head-dips (four holes) and % visit of the baited hole (1 on 4) during 6 min of acquisition phase for Disciminitation 1 (D1) and for Discrimination 2 (D2). All mice are included in the memory retrieval test.
for vehicles; Scheffe post hoc test, P < 0.05) but spared correct responses % for D2 (37.9% ± 4.3% vs 44.7% ± 2.0%; NS).
Discrimination effect Vehicle-treated mice exhibited a higher % of correct responses for D2 (44.7% ± 2.0%) as compared to D1 (25.3% ± 3.3%;
Scheffe post hoc test: P < 0.01) whereas correct responses % of ciproxifantreated animals were not different between both discrimination (36.0% ± 3.7% vs 37.9% ± 4.3% for D1 and D2 respectively; NS).
Stress effect on correct responses
In vehicle group, stress differently altered correct responses rates as a function of discrimination (interaction between discrimination and stress: F(2, 38) = 54.97; P < 0.0001): it decreased the retrieval of D1 correct responses (from 48.5% ± 2.3% for nonstressed Veh.
animals to 25.3% ± 3.3% for stressed Veh. group; P < 0.0001) but increased correct responses for D2 (from 27.6% ± 3.0% for NS Veh.
to 44.7% ± 2.0% for Str.Veh.; P < 0.001). In contrast, for ciproxifantreated animals, stress did not alter correct responses whatever the discrimination (F(2, 49) = 0.80, NS).
Spatial responses
A global ANOVA revealed no significant interaction between drug, discrimination and stress factors (F(3, 87) = 0.04; NS; Figure 2B ).
Performance of spatial responses were all above chance level (50%; t = 6.76, t = 6.01, t = 15.32, t = 6.82, t = 9.16, t = 9.18, t = 14.23 and t = 8.69, P < 0.0001 for all groups, respectively, vehicle NS-D1, vehicle NS-D2, cipro3 NS-D1, cipro3 NS-D2, vehicle Str-D1, vehicle
Str-D2,,cipro3 Str-D1 and cipro3 Str-D2).
| Fos expression in hippocampus, prefrontal cortex and amygdala
In all groups, CSD behavioral test increased significantly Fos immunostaining as compared to naive (nonbehaving) mice (P < 0.0001 in all comparisons and for all brain areas).
Ciproxifan effect
In nonstressed animals, ciproxifan increased Fos positive cells significantly in the BLA (ratio ×1.7; NS Veh. versus NS Cipro3, unpaired t test: t = 2.20, P < 0.05; Figure 3C ) and with a trend in CeA (ratio: ×1.8; t = 1.96, P = 0.06) and PrL (ratio: ×1.3; t = 1.87, P = 0.07; Figure 3A ). No ciproxifan effect was observed in stressed animals.
Stress effect
In vehicle-treated mice, stress significantly increased Fos expression in the Il (ratio: ×1.6; NS Veh. versus Str. Veh.; t = 4.19, P < 0.001), PrL (ratio: ×1.6; unpaired t test, t = 3.52, P < 0.01), the CA1 (ratio: ×2.5; t = 2.22, P < 0.05), BLA (ratio: ×1.6; t = 2.84, P < 0.01) and CeA (ratio ×2.7; t = 5.46, P < 0.0001). In contrast, stress did not impair Fos expression in ciproxifan-treated animals in any brain area.
| Experiment 2
| Elevated plus maze
Distance travelled in open-arms ( Figure 4A ). A two-way ANOVA performed in all groups showed a nonsignificant effect of drug (F(1, 36) < 1.0), a significant effect of stress (F(1, 36) = 16.9; P = 0.001) and a nonsignificant drug and stress interaction (F(2, 36) = 2.5; P = 0.12).
Stress effect
No significant stress effect on open arm distance was found in ciproxifan-treated mice (235.1 ± 37.2 cm vs 151.2 ± 29.7 cm for nonstressed and stressed ciproxifan-treated animals respectively; NS).
In contrast, stress reduced the distance travelled in open-arms in vehicle-treated animals (288.6 ± 18.2 cm vs 100.6 ± 25.9 cm for nonstressed and stressed vehicle-treated animals, respectively; P < 0.01). 
Ciproxifan effect
Ciproxifan did not significantly modify the open arm time ratio both in nonstressed (30.2% ± 4.8%; vs 37.5% ± 3.7%, respectively, for NS Cipro3 and NS Veh. groups; NS) and stressed animals (23.3% ± 4.8%; vs 12.9% ± 4.0% respectively for Cipro3 and Veh.
groups; NS).
Stress effect
No significant stress effect was found in ciproxifan-treated mice (from 30.2% ± 4.8% to 23.3% ± 4.78% for nonstress and stress ciproxifan-treated groups respectively; NS). In contrast in vehicles, stress decreased the percentage of time in open-arms (from 37.5% ± 3.4% to 12.9% ± 4.0% for nonstress and stress vehicletreated groups respectively; P < 0.01).
Ratio Entry. A two-way ANOVA performed in all groups showed a nonsignificant effect of drug (F(1, 36) = 0.75), a nonsignificant effect of stress (F(1, 36) = 0.58) and a nonsignificant drug and stress interaction (F(2, 36) = 0.89;data not shown).
F I G U R E 3 Fos protein expression induced by acute stress and ciproxifan after CSD task. Upper part. Representative photomicrographs of Fos immunopositive neurons in the PL, the CA1 of the hippocampus and the BLA of the amygdala (magnification ×20; scale bar: 100 µm). Lower part. Fos positive cell number are expressed by mean + SEM relative to naive animal level for prefrontal cortex (IL = infralimbic cortex; PrL = prelimbic cortex; A) dorsal hippocampus (CA1; CA3 for cornu ammonis; DG = dentate gyrus; B) and amygdala (LA = lateral amygdala; BLA = basolateral amygdala; CeA = central amygdala; C). Mean were calculated from three representative brain slices for vehicle (Veh) and ciproxifan 3 mg/kg (Cipro3) groups. Stress effect (unpaired t test): *P < 0.05, **P < 0.01, ***P < 0.001. Ciproxifan effect (unpaired t test):
•P < 0.05. The numbers of mice per group are: Il (11, 8, 12, 10) , PrL (11, 8, 12, 10) , Hippocampus (12, 13, 15, 13) , Amygdala (12, 9, 13, 11) 
| Plasma corticosterone levels
A two-way ANOVA performed in all groups showed a significant effect of stress (F(1, 36) = 15.52; P < 0.001), but not of drug (F(1, 36) = 1.91; NS) and a nonsignificant drug and stress interaction (F(2, 36) = 1.45; NS; Figure 4D ).
Stress effect
Stress did not significantly alter plasma corticosterone levels in ciproxifan-treated animals (from 22.2 ± 2.0 µg/dL to 29.1 ± 1.9 µg/ dL, respectively, for NS Cipro3 and Str Cipro3 groups; NS) whereas it increased levels of the vehicle group (from 15.8 ± 2.3 µg/dL to 28.6 ± 3.6 µg/dL, respectively, for NS vehicle and Str Vehicle: P < 0.01).
| D ISCUSS I ON
Main results are as follows. In experiment 1, ciproxifan (3 mg/kg) enhanced contextual memory retrieval both in nonstress and stress con- 
| Stress, ciproxifan, and memory retrieval
It has been reported that compounds activating histamine receptors H1 and/or H2 or increasing histamine release (via H3 histamine receptor blockade) substantially improve memory processes. 4, [7] [8] [9] [11] [12] [13] [14] [15] [16] In our study, ciproxifan did not modify spatial memory performance that were already high (around 70%) in control animals, suggesting likely a ceiling effect. In contrast, a procognitive impact of ciproxifan is observed on contextual memory (see also 15, 21 ). The sparing of spatial but not contextual memory retrieval after stress in the CSD task agrees with studies showing that flexible forms of memory are more vulnerable to the deleterious effects of stress as compared to stable ones. 51 Spatial memory in CSD procedure evaluates a reference memory component. In contrast, "correct" responses depended on the retrieval of a unique internal context (floor) which is associated to a specific spatial location; thus, contextual memory could be an index of the flexible memory processes involved in declarative-like memory in animals. 48 A specific contribution of our study is to show that this improvement is observed on the retrieval phase of memory processes, and both in nonstress and stress conditions. Indeed, it has been reported that histamine may act differently on memory consolidation according to the emotional component of the task. [52] [53] [54] The fact that a memory-enhancing effect is observed in both nonstress and stress conditions in ciproxifan-treated mice may be due to the fact that antagonists of H 3 receptors have a wide range of effects on several neurotransmitters systems (acetylcholine, dopamine) involved at different levels in memory processes.
In the CSD task, in nonstress and stress conditions, both D1
and D2 are accurately and equally retrieved in ciproxifan-treated mice, in contrast to nonstressed (D1 > D2) or stressed (D2 > D1)
vehicle-treated mice. Fos immnostaining showed that ciproxifan in nonstressed animals increased Fos immunoreactivity in the BLA and only a trend for prelimbic cortex and central amygdala which have previously been found to sustain memory retrieval of D2. 43, 44 One would expect an increase of Fos levels in hippocampus of ciproxifan nonstressed animals because previous work showed a crucial role of hippocampus in D1 retrieval. This discrepancy may be due to the lack of sensitivity of Fos immunostaining and/or the behavior may be related to other brain area activity connected to the F I G U R E 4 Elevated plus maze and corticosterone levels (experiment 2 
| Acute stress, ciproxifan, anxiety, and corticosterone levels
Plasma corticosterone concentrations are increased after stress only in vehicle-treated animals whereas ciproxifan blocked the stress-induced plasma corticosterone increase. In contrast, studies have shown that the injection of histamine in the paraventricular nucleus of the hypothalamus activates the HPA axisvia the release of CRH which in turn leads to massive release of corticosteroids. 55 To explain this discrepancy, it could be hypothesized that ciproxifan (injected 35 minutes before blood sampling) could activate hippocampus and/or prefrontal cortex neurons 9 that exert a negative feedback on the HPA axis activity, leading to dampened corticosterone levels. 56 In the present experimental paradigm, ciproxifan did not increase corticosterone levels also in nonstressed animals probably via a masking effect because the behavioral task itself induces corticosterone release. 44 It is known that the release of histamine induced anxiety-like reactivity through the activation of H1 receptors. 39, [57] [58] [59] Injection of H 3 agonists induces anxiolytic-like effects 40, 57, 58 whereas antagonists induce dose-dependent anxiogenic-like effects. 57 Thus, in the present study, one would have expected that the administration of ciproxifan would have modified emotional reactivity in the EPM task. Our results evidenced mitigated effects. Indeed, on the one hand, ciproxifan 3 mg/kg does not induce significant anxiogenic-like effects in nonstressed mice; on the other hand, the deleterious effects of stress on the time spent in open-arms were not observed in ciproxifan-treated mice. Since the procognitive impact of ciproxifan in the CSD task is observed both in nonstress and stress conditions, this indicates that the 3 mg/kg procognitive dose of ciproxifan does not depend on its emotional or endocrinal effects, at least in our experimental conditions.
| CON CLUS ION
Ciproxifan 3 mg/kg enhanced contextual memory retrieval, both in stress and nonstress conditions and dampened emotional reactivity and glucocorticoid responses to an acute stress. Overall, this study emphasized the usefulness of H3 receptor antagonist to enhance cognitive functions both in stress and nonstress conditions.
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